Literature DB >> 24294636

Medicare program; end-stage renal disease prospective payment system, quality incentive program, and durable medical equipment, prosthetics, orthotics, and supplies.

.   

Abstract

This rule updates and makes revisions to the End-Stage Renal Disease (ESRD) prospective payment system (PPS) for calendar year (CY) 2014. This rule also sets forth requirements for the ESRD quality incentive program (QIP), including for payment year (PY) 2016 and beyond. In addition, this rule clarifies the grandfathering provision related to the 3-year minimum lifetime requirement (MLR) for Durable Medical Equipment (DME), and provides clarification of the definition of routinely purchased DME. This rule also implements budget-neutral fee schedules for splints and casts, and intraocular lenses (IOLs) inserted in a physician's office. Finally, this rule makes a few technical amendments and corrections to existing regulations related to payment for durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) items and services.

Entities:  

Mesh:

Year:  2013        PMID: 24294636

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  11 in total

1.  A wearable artificial kidney for patients with end-stage renal disease.

Authors:  Victor Gura; Matthew B Rivara; Scott Bieber; Raj Munshi; Nancy Colobong Smith; Lori Linke; John Kundzins; Masoud Beizai; Carlos Ezon; Larry Kessler; Jonathan Himmelfarb
Journal:  JCI Insight       Date:  2016-06-02

2.  Rebasing the Medicare payment for dialysis: rationale, challenges, and opportunities.

Authors:  Diane Wish; Doug Johnson; Jay Wish
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-04       Impact factor: 8.237

3.  The role of 30-day readmission as a measure of quality.

Authors:  Jay B Wish
Journal:  Clin J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 8.237

4.  Reforming medicare's dialysis payment policies: implications for patients with secondary hyperparathyroidism.

Authors:  Charu Gupta; Glenn M Chertow; Mark T Linthicum; Karen Van Nuys; Vasily Belozeroff; Darryl Quarles; Darius N Lakdawalla
Journal:  Health Serv Res       Date:  2014-07-07       Impact factor: 3.402

5.  Uncorrected and Albumin-Corrected Calcium, Phosphorus, and Mortality in Patients Undergoing Maintenance Dialysis.

Authors:  Matthew B Rivara; Vanessa Ravel; Kamyar Kalantar-Zadeh; Elani Streja; Wei Ling Lau; Allen R Nissenson; Bryan Kestenbaum; Ian H de Boer; Jonathan Himmelfarb; Rajnish Mehrotra
Journal:  J Am Soc Nephrol       Date:  2015-01-22       Impact factor: 10.121

6.  Legal Issues for the Medical Director.

Authors:  William G Trulove
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-09       Impact factor: 8.237

7.  Chemistry Testing on Plasma Versus Serum Samples in Dialysis Patients: Clinical and Quality Improvement Implications.

Authors:  Roger Neill Carey; Chinu Jani; Curtis Johnson; Jim Pearce; Patricia Hui-Ng; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-16       Impact factor: 8.237

Review 8.  The changing landscape of home dialysis in the United States.

Authors:  Matthew B Rivara; Rajnish Mehrotra
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

9.  Evaluation of the consumer assessment of healthcare providers and systems in-center hemodialysis survey.

Authors:  Robert Wood; Carly J Paoli; Ron D Hays; Gavin Taylor-Stokes; James Piercy; Matthew Gitlin
Journal:  Clin J Am Soc Nephrol       Date:  2014-05-15       Impact factor: 8.237

10.  Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients.

Authors:  Steven M Brunelli; Levi Njord; Abigail E Hunt; Scott P Sibbel
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.